SCREENING FOR COLORECTAL-CANCER USING AN IMMUNOCHEMICAL TEST FOR FECAL OCCULT BLOOD - RESULTS OF THE 1ST 2 YEARS OF A SOUTH AUSTRALIAN PROGRAM

被引:12
作者
WELLER, D
THOMAS, D
HILLER, J
WOODWARD, A
EDWARDS, J
机构
[1] UNIV ADELAIDE,DEPT COMMUNITY MED,ADELAIDE,SA 5001,AUSTRALIA
[2] INST MED & VET SCI,ADELAIDE,SA 5000,AUSTRALIA
来源
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY | 1994年 / 64卷 / 07期
关键词
COLORECTAL CANCER; FECAL OCCULT BLOOD TESTING; IMMUNOCHEMICAL FECAL OCCULT BLOOD TESTS; SCREENING;
D O I
10.1111/j.1445-2197.1994.tb02257.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
This paper reports an evaluation of the first 2 years of a South Australian screening programme for colorectal cancer which was established in 1988 by the Institute of Medical and Veterinary Science. The programme uses an immunochemical test for faecal occult blood. Based on 1 year of follow-up, over the period of this analysis there were 24 cancers and 99 adenomas detected in 6208 participants, and the estimated sensitivity and specificity of the test (for colorectal cancer) were 82.8 and 95.9%, respectively. In many cases the test was used to detect recurrence of disease in individuals with a previous diagnosis of colorectal cancer. The estimated predictive value of a positive test for colorectal cancer in this population was 7.5%. Results suggest that participants belonged to higher-than-average socio-economic groups and were more likely than the general population to have a family history of colorectal cancer. Almost one-third had suffered from bowel symptoms in the 6 months before taking the test. These unique characteristics of participants, which limit the generalizability of results to the wider population, may result from the programme's reliance on self-recruitment methods. Consistent evidence for improvements in mortality in populations screened for colorectal cancer is still required before a recommendation for widespread screening in Australia can be made.
引用
收藏
页码:464 / 469
页数:6
相关论文
共 50 条
  • [41] Multitarget stool DNA test compared with fecal occult blood test for colorectal cancer screening
    Yang, Cuiping
    Wu, Wei
    Yang, Yanping
    Yang, Xiaojin
    Sun, Jing
    Zhang, Weiyu
    Liu, Kun
    Ying, Haifeng
    Jiang, Songyao
    Yu, Xiaojun
    Shi, Yiqing
    Zhou, Yufen
    Zhu, Shiyan
    Xu, Ying
    Ding, Yanfei
    Xie, Ling
    Cai, Boer
    Xin, Xiaorong
    Chen, Ping
    Zhao, Ren
    Wu, Yunlin
    ONCOLOGY LETTERS, 2020, 20 (02) : 1193 - 1200
  • [42] Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: A prospective cohort study in Japan
    Lee, Kyung-Jae
    Inoue, Manami
    Otani, Tetsuya
    Iwasaki, Motoki
    Sasazuki, Shizuka
    Tsugane, Shoichiro
    CANCER DETECTION AND PREVENTION, 2007, 31 (01): : 3 - 11
  • [43] A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. a prospective, controlled, feasibility study
    Levi, Zohar
    Birkenfeld, Shlomo
    Vilkin, Alex
    Bar-Chana, Micha
    Lifshitz, Irena
    Chared, Miri
    Maoz, Eran
    Niv, Yaron
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (10) : 2415 - 2424
  • [44] Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: A comparison of two invitation strategies
    Van Roosbroeck, Sofie
    Hoeck, Sarah
    Van Hal, Guido
    CANCER EPIDEMIOLOGY, 2012, 36 (05) : E317 - E324
  • [45] Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study
    Li, SR
    Nie, ZH
    Li, N
    Li, JX
    Zhang, P
    Yang, ZX
    Mu, SK
    Du, YP
    Hu, JC
    Yuan, SY
    Qu, HT
    Zhang, TC
    Wang, SX
    Dong, EY
    Qi, DF
    CHINESE MEDICAL JOURNAL, 2003, 116 (02) : 200 - 202
  • [46] Is It Necessary to Repeat Fecal Occult Blood Tests with Borderline Results for Colorectal Cancer Screening?
    Lee, Eunyoung
    Lee, Yangsoon
    ANNALS OF LABORATORY MEDICINE, 2018, 38 (01) : 51 - 53
  • [47] Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea
    Kim, Dae Ho
    Cha, Jae Myung
    Kwak, Min Seob
    Yoon, Jin Young
    Cho, Young-Hak
    Jeon, Jung Won
    Shin, Hyun Phil
    Joo, Kwang Ro
    Lee, Joung Il
    GUT AND LIVER, 2018, 12 (02) : 183 - 189
  • [48] Veterans' Continued Participation in an Annual Fecal Immunochemical Test Mailing Program for Colorectal Cancer Screening
    Schlichting, Jennifer A.
    Mengeling, Michelle A.
    Makki, Nader M.
    Malhotra, Ashish
    Halfdanarson, Thorvardur R.
    Klutts, J. Stacey
    Levy, Barcey T.
    Kaboli, Peter J.
    Charlton, Mary E.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2015, 28 (04) : 494 - 497
  • [49] Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB)
    Syrjaenen, Kari
    Eskelinen, Maaret
    Meklin, Jannica
    Hendolin, Panu
    Eskelinen, Matti
    Suovaniemi, Osmo
    ANTICANCER RESEARCH, 2024, 44 (04) : 1513 - 1523
  • [50] Costs and Benefits of an Organized Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in the United States
    Guy, Gery P., Jr.
    Richardson, Lisa C.
    Pignone, Michael P.
    Plescia, Marcus
    CANCER, 2014, 120 (15) : 2308 - 2315